122 related articles for article (PubMed ID: 19567077)
21. ALDH, CA I, and CD2AP: novel, diagnostically useful immunohistochemical markers to identify erythroid precursors in bone marrow biopsy specimens.
Rollins-Raval MA; Fuhrer K; Marafioti T; Roth CG
Am J Clin Pathol; 2012 Jan; 137(1):30-8. PubMed ID: 22180476
[TBL] [Abstract][Full Text] [Related]
22. Unusual case of multilocular cystic renal cell carcinoma treated with nephron-sparing technique.
Papadimitriou VG; Takos D; Adamopoulos V; Vegertaki U; Heretis JM; Stamatiou KN; Sofras FA
G Chir; 2009; 30(8-9):345-8. PubMed ID: 19735612
[TBL] [Abstract][Full Text] [Related]
23. Tyrosine Phosphorylation of CD2AP Affects Stability of the Slit Diaphragm Complex.
Tossidou I; Teng B; Worthmann K; Müller-Deile J; Jobst-Schwan T; Kardinal C; Schroder P; Bolanos-Palmieri P; Haller H; Willerding J; Drost DM; de Jonge L; Reubold T; Eschenburg S; Johnson RI; Schiffer M
J Am Soc Nephrol; 2019 Jul; 30(7):1220-1237. PubMed ID: 31235616
[TBL] [Abstract][Full Text] [Related]
24.
Kim SH; Park WS; Chung J
Investig Clin Urol; 2019 May; 60(3):148-155. PubMed ID: 31098421
[TBL] [Abstract][Full Text] [Related]
25. Ghrelin expression in normal kidney tissue and renal carcinomas.
Dagli AF; Aydin S; Karaoglu A; Akpolat N; Ozercan IH; Ozercan MR
Pathol Res Pract; 2009; 205(3):165-73. PubMed ID: 19054628
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of CD44s in conventional renal cell carcinomas with renal vein or vena cava thrombosis. a retrospective evaluation of the expression of CD44s by immunohistochemical analysis in conventional RCC patients and in conventional RCC patients with renal vein or vena cava thrombosis.
Altinel M; Arpali E; Turhan N; Gonenc F; Yazicioglu A
Urol Int; 2008; 81(4):452-5. PubMed ID: 19077409
[TBL] [Abstract][Full Text] [Related]
27. CD2AP is expressed with nephrin in developing podocytes and is found widely in mature kidney and elsewhere.
Li C; Ruotsalainen V; Tryggvason K; Shaw AS; Miner JH
Am J Physiol Renal Physiol; 2000 Oct; 279(4):F785-92. PubMed ID: 10997929
[TBL] [Abstract][Full Text] [Related]
28. D2-40 is a sensitive and specific marker in differentiating primary adrenal cortical tumours from both metastatic clear cell renal cell carcinoma and phaeochromocytoma.
Browning L; Bailey D; Parker A
J Clin Pathol; 2008 Mar; 61(3):293-6. PubMed ID: 17660332
[TBL] [Abstract][Full Text] [Related]
29. The expression of thrombospondin-1 and p53 in clear cell renal cell carcinoma: its relationship to angiogenesis, cell proliferation and cancer specific survival.
Zubac DP; Bostad L; Kihl B; Seidal T; Wentzel-Larsen T; Haukaas SA
J Urol; 2009 Nov; 182(5):2144-9. PubMed ID: 19758660
[TBL] [Abstract][Full Text] [Related]
30. CIAPIN1 inhibits the growth and proliferation of clear cell renal cell carcinoma.
He L; Wang H; Jin H; Guo C; Xie H; Yan K; Li X; Shen Q; Qiao T; Chen G; Chai N; Zhao L; Dong Q; Zheng Y; Liu J; Fan D
Cancer Lett; 2009 Apr; 276(1):88-94. PubMed ID: 19081179
[TBL] [Abstract][Full Text] [Related]
31. Specific reduction of fas-associated protein with death domain (FADD) in clear cell renal cell carcinoma.
Xu H; He L; Feng X; Kapoor A; Tang D
Cancer Invest; 2009 Oct; 27(8):836-43. PubMed ID: 19557578
[TBL] [Abstract][Full Text] [Related]
32. [CT differential diagnosis of cystic nephroma and multilocular cystic renal cell carcinoma].
Zhao J; Ye Z; Bai R; Chen X; Pan Y
Zhonghua Zhong Liu Za Zhi; 2015 Nov; 37(11):845-9. PubMed ID: 26887516
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Csk-binding protein contributes to renal cell carcinogenesis.
Feng X; Lu X; Man X; Zhou W; Jiang LQ; Knyazev P; Lei L; Huang Q; Ullrich A; Zhang Z; Chen Z
Oncogene; 2009 Sep; 28(37):3320-31. PubMed ID: 19581936
[TBL] [Abstract][Full Text] [Related]
34. Association of CD2AP with dynamic actin on vesicles in podocytes.
Welsch T; Endlich N; Gökce G; Doroshenko E; Simpson JC; Kriz W; Shaw AS; Endlich K
Am J Physiol Renal Physiol; 2005 Nov; 289(5):F1134-43. PubMed ID: 15956777
[TBL] [Abstract][Full Text] [Related]
35. Multilocular cystic renal cell carcinoma in lower pole moiety of a duplex kidney.
Liu GM; Ma HS; Li YM
Int J Surg Pathol; 2012 Dec; 20(6):613-7. PubMed ID: 22456872
[TBL] [Abstract][Full Text] [Related]
36. Glypican-3 is expressed in chromophobe renal cell carcinomas.
Okoń K
Pol J Pathol; 2008; 59(1):15-20. PubMed ID: 18655366
[TBL] [Abstract][Full Text] [Related]
37. [Multilocular cystic renal cell carcinoma].
Farah-Klibi F; Ferchichi L; Bouzouita A; Sfaxi M; Chebil M; Baltagi Ben Jilani S; Zermani R
Tunis Med; 2009 Mar; 87(3):222-4. PubMed ID: 19537021
[TBL] [Abstract][Full Text] [Related]
38. Cystic nephroma in adults. A report of two cases and review of the literature.
Duda-Szymańska J; Kaczmarek J; Papierz W
Pol J Pathol; 2005; 56(2):93-6. PubMed ID: 16092672
[TBL] [Abstract][Full Text] [Related]
39. The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.
Voss M; Steidler A; Grobholz R; Weiss C; Alken P; Michel MS; Trojan L
BJU Int; 2009 Jul; 104(1):94-9. PubMed ID: 19500329
[TBL] [Abstract][Full Text] [Related]
40. Multilocular Cystic Renal Cell Neoplasm of Low Malignant Potential: A Series of 76 Cases.
Li T; Chen J; Jiang Y; Ning X; Peng S; Wang J; He Q; Yang X; Gong K
Clin Genitourin Cancer; 2016 Dec; 14(6):e553-e557. PubMed ID: 27108004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
